BBH Holdings — VanEck Biotech ETF
All 25 reported holdings of VanEck Biotech ETF (BBH) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Amgen Inc | 15.25% | $60.32M |
| Gilead Sciences Inc | 12.79% | $50.58M |
| Vertex Pharmaceuticals Inc | 9.10% | $36.01M |
| Regeneron Pharmaceuticals Inc | 6.21% | $24.56M |
| Revolution Medicines Inc | 5.27% | $20.86M |
| Argenx SE | 4.97% | $19.67M |
| Natera Inc | 4.92% | $19.46M |
| IQVIA Holdings Inc | 4.31% | $17.03M |
| Alnylam Pharmaceuticals Inc | 3.83% | $15.16M |
| Biogen Inc | 3.63% | $14.35M |
| Moderna Inc | 3.36% | $13.30M |
| Illumina Inc | 3.17% | $12.54M |
| United Therapeutics Corp | 2.83% | $11.18M |
| BeOne Medicines Ltd | 2.81% | $11.11M |
| Insmed Inc | 2.67% | $10.56M |
| Incyte Corp | 2.49% | $9.86M |
| Neurocrine Biosciences Inc | 2.08% | $8.24M |
| BioNTech SE | 1.94% | $7.68M |
| Icon PLC | 1.90% | $7.52M |
| Bio-Techne Corp | 1.54% | $6.10M |
| Charles River Laboratories International Inc | 1.50% | $5.94M |
| BioMarin Pharmaceutical Inc | 1.34% | $5.29M |
| Qiagen NV | 1.06% | $4.21M |
| Tempus AI Inc | 0.98% | $3.89M |
| State Street Global Advisors | 0.06% | $233.72K |